Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Nantkwest Inc CS (NK)

3.97 0.05 (1.28%)

05-18 16:00

Open:

4

Pre. Close:

3.92

High:

4.05

Low:

3.91

Volume:

113,593

Market Cap:

310M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.052 - 4.076

4.076 - 4.1

Low:

3.853 - 3.881

3.881 - 3.909

Close:

3.926 - 3.968

3.968 - 4.009

Technical analysis  (as of: 2018-05-18 4:35:47 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 4.86     One year: 5.14

Support:

Support1: 3.78    Support2: 3.14

Resistance:

Resistance1: 4.16    Resistance2: 4.40

Pivot:

4.00

Moving Averages:

MA(5): 4.04     MA(20): 4.02

MA(100): 4.24     MA(250): 4.99

MACD:

MACD(12,26): 0.01     Signal(12,26,9): 0.01

%K %D:

%K(14,3): 29.57     %D(3): 39.43

RSI:

RSI(14): 48.23

52-Week:

High: 8.449  Low: 3.41  Change(%): 2.6

Average Vol(K):

3-Month: 17247  10-Days 13635

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
NK has closed above bottom band by 41.6%. Bollinger Bands are 53.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to NK's normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-24T14:28:02-04:00
By The Numbers: Healthcare Stocks With Big Cash Distributions

2018-04-23T15:18:00-04:00
NantKwest to Present at Upcoming Science & Medicine Conferences

2018-04-02T11:28:31-04:00
NantHealth Has Turned A Corner

2018-03-20T12:08:33-04:00
Unum Therapeutics Updates Proposed IPO Terms

2018-03-13T19:29:00-04:00
NantKwest to Present at Upcoming Investment and Healthcare Conferences

2018-02-15T08:01:00-05:00
Your Daily Pharma Scoop: Achaogen Update, Catabasis' Positive Results, Bristol-Myers Squibb/Nektar Collaboration

2018-02-13T11:31:48-05:00
Early-stage study underway assessing Nantkwest's HER2.taNK in brain cancer; shares up 2%

2018-02-13T08:00:00-05:00
Nantkwest and Frankfurt University Hospital Announce First in Human Dosing of off-the-Shelf HER2.taNK (Car-natural Killer) Cell Therapy in Glioblastoma

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

78.09

Shares Float (M)

73.41

% Held by Insiders

5.90

% Held by Institutions

15.40

Shares Short (K)

3242

Shares Short Prior Month (K)

3990

Stock Financials

EPS

-0.900

EPS Est. Current Year

-1.250

EPS Est. Next Year

-1.470

EPS Est. Next Quarter

-0.350

Forward EPS

-1.470

Book Value (p.s.)

1.620

PEG Ratio

1.59

Profit Margin

Operating Margin

-261384.63

Return on Assets (ttm)

-37.3

Return on Equity (ttm)

-41.5

Qtrly Rev. Growth

-54.5

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.867

Qtrly Earnings Growth

Operating Cash Flow (M)

-54.23

Levered Free Cash Flow (M)

-52.08

atoplab.com

Valuation

P/E

-4.41

P/E Growth Ratio

0.01

P/BV

2.45

P/S

P/CF

-5.72

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-08-17

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.